Expertise in
5
conditions

Dr. Michael E. Beck

Internal Medicine
Carmen Gnatenco M.D. SC
4938 W 95th St, 
Oak Lawn, IL 
Expertise in
5
conditions
Carmen Gnatenco M.D. SC
4938 W 95th St, 
Oak Lawn, IL 

Overview

Michael Beck is a primary care provider, practicing in Internal Medicine in Oak Lawn, Illinois.

Dr. Beck is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Fabry Disease, Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A), Gastrostomy, and Carotid Artery Surgery.

He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 2 clinical trials.

Specialties

Internal Medicine

Licenses

Specialist in IL

Hospital Affiliations

Loyola University Medical Center
Osf Little Company Of Mary Medical Center
Advocate Christ Hospital & Medical Center
Palos Community Hospital
Advocate Good Samaritan Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Carmen Gnatenco M.D. SC
4938 W 95th St, Oak Lawn, IL 60453

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

69 Total Publications

Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 14, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Robert E. Molokie
Internal Medicine
Expertise in
8
conditions
Dr. Robert E. Molokie
Internal Medicine

University Of Illinois Hospital

1740 W Taylor St, 
Chicago, IL 
 (11.0 miles away)
312-413-8666
Languages Spoken:
English
See accepted insurances

Robert Molokie is a primary care provider, practicing in Internal Medicine in Chicago, Illinois. Dr. Molokie is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Expertise in
9
conditions
Dr. Michel Gowhari
Internal Medicine
Expertise in
9
conditions
Dr. Michel Gowhari
Internal Medicine

University Of Illinois Hospital

1331 W 75th St, 
Naperville, IL 
 (22.2 miles away)
866-600-2273
Languages Spoken:
English
See accepted insurances

Michel Gowhari is a primary care provider, practicing in Internal Medicine in Naperville, Illinois. Dr. Gowhari is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Expertise in
15
conditions
Dr. Ami A. Shah
Internal Medicine
Expertise in
15
conditions
Dr. Ami A. Shah
Internal Medicine

Advocate Lutheran General Hospital

1775 Dempster St, 
Park Ridge, IL 
 (22.6 miles away)
847-723-2210
Languages Spoken:
English
See accepted insurances

Ami Shah is a primary care provider, practicing in Internal Medicine in Park Ridge, Illinois. Dr. Shah is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Myositis.

Frequently Asked Questions about Dr. Michael E. Beck

How do I make an appointment with Dr. Michael E. Beck?

You can book an appointment with Dr. Michael E. Beck by calling their office at 708-425-4662. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael E. Beck a top-rated expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael E. Beck is classified as an Distinguished expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael E. Beck specialize in?

While Dr. Michael E. Beck is a Internal Medicine, they have specific expertise in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Fabry Disease, and Mucopolysaccharidosis Type 4A (MPS IVA, Morquio Syndrome Type A). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Michael E. Beck participate in research or clinical trials?

Yes. Dr. Michael E. Beck has published 69 articles and abstracts on conditions like Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). You can view a list of Dr. Michael E. Beck's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael E. Beck accept my insurance?

Dr. Michael E. Beck accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 708-425-4662 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Beck's expertise for a condition
ConditionClose
    View All 99 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile